I’m excited to share a blog I wrote for an innovative epitranscriptomics company, AlidaBio, where I serve as a Scientific Advisor.

This piece explores how RNA modifications are emerging as a key layer of biological regulation in cancer progression, with potential implications for diagnostics and therapeutic response.

Read the full blog here:
How RNA Modifications Shape Cancer Progression

Why this matters

RNA modifications such as m6A and A-to-I editing represent a dynamic and mechanistically rich layer of biology that sits between genomics and proteomics. Unlike static DNA mutations, these marks can change rapidly in response to therapy or immune pressure, offering a potential window into:

  • Early tumor adaptation
  • Immune evasion mechanisms
  • Chemotherapy resistance pathways

This is an area I believe will play an increasingly important role in next-generation diagnostics and precision oncology.